CNOT4

Across TCGA pan-cancer cohorts, CNOT4 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CNOT4 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher CNOT4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CNOT4 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUSC show a favorable association.

THYM, READ, and SKCM are the cancer types where CNOT4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
READ	DFS	Median	III,IV	0.182	0.745	.007	12	view →
SKCM	OS	Median	II,III,IV	0.754	0.285	.007	10	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
ESCA	DFS	Median	All	0.075	0.504	<.001	6	view →
LUSC	DFS	Median	All	1.000	0.635	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CNOT4–THYM (OS)

Open the THYM breakdown →